m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00684)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
PRMT5
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | Pancreatic islets | Mus musculus |
Treatment: Mettl3 knockout mice
Control: Mettl3 flox/flox mice
|
GSE155612 | |
Regulation |
|
logFC: 7.02E-01 p-value: 6.96E-04 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between PRMT5 and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 5.94E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 intensified the metastasis and proliferation of OSCC by modulating the m6A amounts of Protein arginine N-methyltransferase 5 (PRMT5) and PD-L1. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Oral squamous cell carcinoma | ICD-11: 2B6E.0 | ||
Pathway Response | PD-L1 expression and PD-1 checkpoint pathway in cancer | hsa05235 | ||
In-vitro Model | SCC-9 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1685 |
SCC-4 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1684 | |
SCC-25 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1682 | |
CAL-27 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1107 | |
In-vivo Model | Six-week-old nude mice were randomly divided into two groups (three mice per group) and cultured with continuous access to sterile food and water in pathogen-free sterile conditions. To establish the OSCC xenograft model, we subcutaneously injected 5 × 106 SCC-9 cells stably transfected with METTL3 shRNA or sh-NC vectors into nude mice. | |||
Head and neck squamous carcinoma [ICD-11: 2B6E]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 intensified the metastasis and proliferation of OSCC by modulating the m6A amounts of Protein arginine N-methyltransferase 5 (PRMT5) and PD-L1. | |||
Responsed Disease | Oral squamous cell carcinoma [ICD-11: 2B6E.0] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | PD-L1 expression and PD-1 checkpoint pathway in cancer | hsa05235 | ||
In-vitro Model | SCC-9 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1685 |
SCC-4 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1684 | |
SCC-25 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1682 | |
CAL-27 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1107 | |
In-vivo Model | Six-week-old nude mice were randomly divided into two groups (three mice per group) and cultured with continuous access to sterile food and water in pathogen-free sterile conditions. To establish the OSCC xenograft model, we subcutaneously injected 5 × 106 SCC-9 cells stably transfected with METTL3 shRNA or sh-NC vectors into nude mice. | |||